Follow
James Joseph Hobson
James Joseph Hobson
Research Co-ordinator, University of Liverpool
Verified email at liverpool.ac.uk - Homepage
Title
Cited by
Cited by
Year
Branched copolymer-stabilised nanoemulsions as new candidate oral drug delivery systems
JJ Hobson, S Edwards, RA Slater, P Martin, A Owen, SP Rannard
RSC advances 8 (23), 12984-12991, 2018
452018
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
JJ Hobson, A Al-Khouja, P Curley, D Meyers, C Flexner, M Siccardi, ...
Nature communications 10 (1), 1413, 2019
352019
Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection
JJ Hobson, AC Savage, AB Dwyer, C Unsworth, J Massam, U Arshad, ...
Nanoscale 13 (13), 6410-6416, 2021
142021
Mucus-responsive functionalized emulsions: design, synthesis and study of novel branched polymers as functional emulsifiers
SE Edwards, S Flynn, JJ Hobson, P Chambon, H Cauldbeck, SP Rannard
RSC advances 10 (51), 30463-30475, 2020
132020
Simulating intestinal transporter and enzyme activity in a physiologically based pharmacokinetic model for tenofovir disoproxil fumarate
DM Moss, P Domanico, M Watkins, S Park, R Randolph, S Wring, ...
Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00105-17, 2017
122017
Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters
M Neary, H Box, J Sharp, L Tatham, P Curley, J Herriott, E Kijak, U Arshad, ...
bioRxiv, 2021.07. 08.451654, 2021
102021
Anhydrous nanoprecipitation for the preparation of nanodispersions of tenofovir disoproxil fumarate in oils as candidate long-acting injectable depot formulations
JJ Hobson, P Curley, AC Savage, A Al-Khouja, M Siccardi, C Flexner, ...
Nanoscale Advances 1 (11), 4301-4307, 2019
62019
The potential value of nanomedicine and novel oral dosage forms in the treatment of HIV
JJ Hobson, A Owen, SP Rannard
Nanomedicine 13 (16), 1963-1965, 2018
32018
Prediction of etravirine pharmacogenetics using a physiologically based pharmacokinetic approach
M Siccardi, A Olagunju, P Curley, J Hobson, S Khoo, D Back, A Owen
20th Conference on Retroviruses and Opportunistic Infections (CROI). Atlanta …, 2013
32013
Evaluation of Nafamostat as chemoprophylaxis for SARS-CoV-2 infection in hamsters
M Neary, J Sharp, E Gallardo-Toledo, J Herriott, E Kijak, C Bramwell, ...
Viruses 15 (8), 1744, 2023
22023
Optimisation and validation of a sensitive bioanalytical method for niclosamide
U Arshad, H Pertinez, H Box, L Tatham, RKR Rajoli, M Neary, J Sharp, ...
bioRxiv, 2021.01. 13.426426, 2021
22021
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
P Curley, JJ Hobson, NJ Liptrott, E Makarov, A Al-Khouja, L Tatham, ...
Pharmaceutics 15 (7), 1835, 2023
12023
Safety assessment of a new nanoemulsion-based drug-delivery system reveals unexpected, drug-free anticoagulant activity
JJ Hobson, SP Rannard, A Owen, NJ Liptrott
Nanomedicine 15 (14), 1361-1373, 2020
12020
Immunological safety assessment and viral efficacy of novel pickering stabilised nanoemulsions containing lopinavir and efavirenz
J Hobson, N Liptrott, S Rannard, A Owen
European Summit for Clinical Nanomedicine, 2013
12013
Pharmaceutically active compound formulations
SP Rannard, A Owen, J Hobson, A Savage, A Dwyer, C Unsworth, ...
US Patent App. 18/252,508, 2023
2023
NAFAMOSTAT AS NASAL CHEMOPROPHYLAXIS FOR SARS-CoV-2 IN HAMSTERS
M Neary, J Sharp, E Gallardo-Toledo, J Herriott, E Kijak, C Bramwell, ...
Topics in Antiviral Medicine, 217-217, 2023
2023
Prodrug compositions
SP Rannard, A Owen, P Curley, J Hobson, M Siccardi, CLF Meyers, ...
US Patent 11,498,933, 2022
2022
Aqueous (co) polymer stabilisers for size-controlled 2–5 nm gold nanoparticle synthesis with tuneable catalytic activity
DJ Traynor, E Ureña-Horno, JJ Hobson, EJ Croft, SE Edwards, ...
New Journal of Chemistry 46 (36), 17282-17291, 2022
2022
Optimisation and validation of a sensitive bioanalytical method for niclosamide (preprint)
U Arshad, H Pertinez, H Box, L Tatham, RKR Rajoli, M Neary, J Sharp, ...
2021
Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters (preprint)
M Neary, H Box, J Sharp, L Tatham, P Curley, J Herriott, E Kijak, U Arshad, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–20